25021-615 : Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride In 0.9% Sodium Chloride 4 ug/ml Intravenous Injection, Solution


NDC: 25021-615
Labeler: Sagent Pharmaceuticals
Product Type: Human Prescription Drug
Drug Name:  Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride
Dosage Form: Intravenous Injection, Solution
Application #: ANDA217308
Rev. Date: 


NDC Package Codes:

  • 25021-615-50: 10 BOTTLE IN 1 CARTON (25021‑615‑50) / 50 ML IN 1 BOTTLE
  • 25021-615-51: 10 BOTTLE IN 1 CARTON (25021‑615‑51) / 100 ML IN 1 BOTTLE

Active Ingredients:

  • Dexmedetomidine Hydrochloride

Dosage Strength:

  • 4 ug/mL

Pharmaceutical Classes:

  • Adrenergic alpha2-Agonists [MoA]
  • Central alpha-2 Adrenergic Agonist [EPC]
  • General Anesthesia [PE]

Related Products:

Based on records with the same trade name.
  • 0781-3493 Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride In 0.9% Sodium Chloride 4 ug/ml Intravenous Injection by Sandoz Inc.
  • 0781-3494 Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride In 0.9% Sodium Chloride 4 ug/ml Intravenous Injection by Sandoz Inc.
  • 0781-3495 Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride In 0.9% Sodium Chloride 4 ug/ml Intravenous Injection by Sandoz Inc.
  • 43066-555 Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride In 0.9% Sodium Chloride 200 ug/50ml Intravenous Injection by Baxter Healthcare Corporation
  • 43066-557 Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride In 0.9% Sodium Chloride 400 ug/100ml Intravenous Injection by Baxter Healthcare Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 25021-615 QR Code

< Prev: 25021-612Next: 25021-651 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.